Diana K. Vania

<p>Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review</p>

Soyon Lee, Diana K. Vania, Menaka Bhor et al. · International Journal of General Medicine · 2020 · 41 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17

Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon<i>β</i>-1a

Melissa A. Frasco, Tiffany Shih, Devin Incerti et al. · Journal of Medical Economics · 2017 · 20 citations

Pharmacy, Neurology, Pharmacoeconomics +17

Value of Comprehensive HCV Treatment among Vulnerable, High-Risk Populations

Gigi A Moreno, Alice Wang, Yuri Sánchez González et al. · Value in Health · 2017 · 18 citations · Full text

Pharmacy, Infectious Disease Control, Pharmacoeconomics +17

Can evidence-based health policy from high-income countries be applied to lower-income countries: considering barriers and facilitators to an organ donor registry in Mumbai, India

Diana K. Vania, Glen E. Randall · Health Research Policy and Systems · 2015 · 13 citations · Full text

Public Affairs, Health Policy, Healthcare Policy +8